SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-20-002409
Filing Date
2020-06-15
Accepted
2020-06-15 16:44:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 ESPERION THERAPEUTICS, INC. p20-1232sc13g.htm SC 13G 64153
  Complete submission text file 0000902664-20-002409.txt   65840
Mailing Address GEORGE HOUSE 131 SLOANE STREET LONDON X0 SW1X 9AT
Business Address GEORGE HOUSE 131 SLOANE STREET LONDON X0 SW1X 9AT 44-207-316-2251
MARSHALL WACE, LLP (Filed by) CIK: 0001318757 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0930
Type: SC 13G

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87536 | Film No.: 20963923
SIC: 2834 Pharmaceutical Preparations